Physician profile
Sandra Rappe
NPI 1548253362
$1,167.39
in general payments reported to CMS, 2019-2025
19 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $40.58 · 2023: $238 · 2024: $426 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $166.97 | 2023-2025 | Evenity, Prolia, Prolia |
| Sumitomo Pharma America, INC. | $123.52 | 2023-2025 | Myfembree |
| Abbvie INC. | $121.55 | 2019-2024 | |
| Astellas Pharma US INC | $121.23 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $114.34 | 2019-2024 | Paragard T 380a, Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $102.37 | 2019-2024 | |
| Sage Therapeutics, LLC | $84.26 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $53.25 | 2025 | Solosec, Phexx, Phexxi |
| Pfizer INC. | $49.44 | 2024-2025 | |
| Exeltis, USA INC. | $43.69 | 2024-2025 | Slynd |
| Roche Diagnostics Corporation | $40.15 | 2019 | |
| Mayne Pharma Commercial LLC | $36.74 | 2023 | |
| Hologic Sales and Service, LLC | $22.80 | 2025 | Aptima, Thinprep 2000 Processor |
| Alexion Pharmaceuticals, INC. | $18.17 | 2019 | |
| Covidien LP | $16.73 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $13.94 | 2019 | |
| Merck Sharp & Dohme LLC | $13.90 | 2025 | Gardasil 9 |
| Radius Health, INC. | $13.39 | 2019 | |
| Lupin INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Rappe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.